- Home
- Immuglo 5% IV Injection
Immuglo 5% IV Injection Substitute
Immuglo 5% IV Injection Substitute
Verified Ingredients and Effects
Composition:
HUMAN NORMAL IMMUNOGLOBULIN-5%W/V
Uses:
Treatment of Immunoglobulin deficiency and inflammatory disorders such as primary immune thrombocytopenia, Guillain-Barre syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.
Medicinal Benefits:
Immuglo 5% IV Injection acts by replacing the deficient antibodies that are necessary to act against infections and inflammation. It works exactly as the immunoglobulins present in the body. Immunoglobulins are an important part of the immune system, which recognizes the antigens or foreign elements in the body and causes their destruction. It is used to treat immunoglobulin deficiency in people with primary immunodeficiency or PID (present from birth) and secondary immunodeficiency or SID (developed in the later stages of life). Immuglo 5% IV Injection is also used to treat inflammatory disorders such as primary immune thrombocytopenia (reduced number of platelets), Guillain-Barre syndrome (short-term inflammation of the peripheral nerves causing weakness of legs and upper limbs), Kawasaki disease (inflammation of blood vessels in children), chronic inflammatory demyelinating polyneuropathy or CIDP (long-term inflammation of peripheral nerves), and multifocal motor neuropathy (progressive disease leading to weakness of arms and legs).
FAQs
Immuglo 5% IV Injection is used to treat immunoglobulin (antibody) deficiency and certain inflammatory disorders.
The Immuglo 5% IV Injection contains 'Human normal immunoglobulin', which helps restore the deficient immunoglobulins or antibodies in the body. Antibodies are an essential part of the immune system that helps to reduce infection and inflammation. They act by identifying, attacking, and thereby destroying the antigen or foreign body that has entered or is present in the body.
Immuglo 5% IV Injection may alter some blood test results for a certain time, so inform your doctor that you have Immuglo 5% IV Injection before undergoing blood tests. Taking any vaccines (especially live vaccines) at least three months after taking Immuglo 5% IV Injection is not recommended as this medicine may make the vaccines less effective.
Immuglo 5% IV Injection should be used with caution in patients with diabetes if this medicine is given as an infusion, as it may alter blood sugar levels. Immuglo 5% IV Injection doesn’t contain sugar; however, it can be diluted in a special sugar solution before giving the infusion.
Immuglo 5% IV Injection is usually well-tolerated. However, some patients may experience side effects such as swelling or hardening at the injection site and headache, pain in the face, back, arms, legs, joints, or neck, fever, flu-like illness (runny nose and sore throat), blisters in the mouth, and throat, and throat tightness. If any side effects persist or get worse, inform your doctor immediately.
It is a condition in which there is a decrease in antibody levels in the body due to decreased ability or inability to produce enough antibodies. It can be present from birth (primary) or acquired during the later stages of life (secondary).
Certain vaccinations, such as those for chickenpox, measles, mumps, and rubella, may become less effective when administered with Immuglo 5% IV Injection . Therefore, before receiving any vaccinations, inform your doctor if you are allergic to Immuglo 5% IV Injection . Let your doctor know that you are taking Immuglo 5% IV Injection . And also inform your doctor if you are breastfeeding, pregnancy or planning pregnancy.
No, you should not discontinue using Immuglo 5% IV Injection without consulting your doctor, even if you feel fine. Stopping the usage of Immuglo 5% IV Injection early can increase the risk of infections. Always follow your doctor's instructions and complete the prescribed course of treatment to ensure the best outcome.
The effects of Immuglo 5% IV Injection can vary depending on the individual and the condition being treated. Generally, it may take up to 4 weeks of regular therapy to notice a steady improvement in your symptoms. Therefore, complete the full course of treatment as prescribed by your doctor.
Yes, Immuglo 5% IV Injection can cause kidney damage but not in everyone. Patients having a pre-existing kidney problem, hypovolemia (a decrease in the volume of circulating blood) and diabetes are at risk of developing kidney failure. Additionally, patients who are overweight, above 65 years of age and who are taking medicines that can cause kidney damage are also at risk of developing kidney failure. Therefore, please inform your doctor if you have any pre-existing kidney problems.
No, hair loss is not a commonly reported side effect of Immuglo 5% IV Injection . If you experience hair loss, it might be due to some other underlying problem. Please consult your doctor if bothers you.
Immuglo 5% IV Injection benefits people with weakened immune systems, such as those who have undergone bone marrow transplants or have severely reduced antibody-forming capacity. It can also treat or prevent infections who are suffering with measles, hepatitis, and mumps. It is used for patients with primary immunodeficiency syndromes (PID) and acquired or secondary immunodeficiency (SID). Please consult your doctor if you have any concerns.
If you are pregnant, take your doctor’s advice before using Immuglo 5% IV Injection . Your doctor will assess the benefits and risks of Immuglo 5% IV Injection before prescribing.
Store Immuglo 5% IV Injection in a refrigerator (2 - 8°C). Do not freeze. Protect it from light. Keep out of reach of children.
No, Immuglo 5% IV Injection should not be self-administered. It is usually administered by a healthcare professional, such as a doctor or nurse.